Publications by authors named "Anna Nappi"

Claim this Profile
T
The Value of Baseline [F]FDG-PET in Predicting the Progression-Free Survival in Patients with Thymic Epithelial Tumours: A Systematic Review and Meta-Analysis.
Alberto Miceli, Maria Librando, Francesco Dondi, Lorenzo Jonghi-Lavarini, Adriana D'Antonio, Anna Giulia Nappi

Diagnostics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.
Alessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, Andrea Casadei-Gardini, Massimo Iavarone, Anna Nappi

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Post Hoc Analysis of Older Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Plus Bevacizumab: The Randomized Obelics Study.
Gerardo Rosati, Maria Carmela Piccirillo, Guglielmo Nasti, Alfonso De Stefano, Chiara Carlomagno, Anna Nappi

Drugs Aging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New.
Anna Giulia Nappi, Francesco Dondi, Achille Lazzarato, Lorenzo Jonghi-Lavarini, Joana Gorica

Hematol Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of and Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.
Antonio Avallone, Francesco Giuliani, Alfonso De Stefano, Giuseppe Santabarbara, Guglielmo Nasti, Anna Nappi

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is whole body low dose CT still necessary in the era of F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients?
Nicola Maggialetti, Cristina Ferrari, Anna Giulia Nappi, Angela Quinto, Bernardo Rossini

Hell J Nucl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?
Francesco Dondi, Alberto Miceli, Guido Rovera, Vanessa Feudo, Claudia Battisti, Anna Giulia Nappi

Bioengineering (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Role of [F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results.
Anna Giulia Nappi, Giulia Santo, Lorenzo Jonghi-Lavarini, Alberto Miceli, Achille Lazzarato

Hematol Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Baseline [F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Andrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, Alessio Annovazzi, Silvia Di Traglia, Anna Giulia Nappi

Cancer Biother Radiopharm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
Alfonso De Stefano, Nicoletta Zanaletti, Antonino Cassata, Lucrezia Silvestro, Anna Nappi

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Anna Giulia Nappi

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The role of oropharyngoesophageal scintigraphy in the assessment of dysphagia in neurological patients.].
Anna Giulia Nappi, Corinna Altini, Claudia D'Alò, Marisa Megna, Artor Niccoli Asabella

Recenti Prog Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]fluciclovine vs. [F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients.
Cristina Ferrari, Paolo Mammucci, Valentina Lavelli, Antonio Rosario Pisani, Anna Giulia Nappi

Tomography· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Network Analysis for Prediction of Unplanned Hospital Readmissions of Cancer Patients with Breakthrough Cancer Pain and Complex Care Needs.
Marco Cascella, Emanuela Racca, Anna Nappi, Sergio Coluccia, Sabatino Maione

Healthcare (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Solitary Fibrous Tumor: A "New" Challenge for PET Radiopharmaceuticals.
Angela Sardaro, Paolo Mammucci, Antonio Rosario Pisani, Dino Rubini, Anna Giulia Nappi

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients.
Anna Giulia Nappi, Cristina Ferrari, Paolo Mammucci, Dino Rubini, Valentina Lavelli

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
Giulia Santo, Riccardo Laudicella, Flavia Linguanti, Anna Giulia Nappi, Elisabetta Abenavoli

Diagnostics (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial.
Erika Martinelli, Giulia Martini, Vincenzo Famiglietti, Teresa Troiani, Stefania Napolitano, Anna Nappi

JAMA Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management.
Cristina Ferrari, Anna Giulia Nappi, Giulia Santo, Paolo Mammucci, Dino Rubini

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Antonio Avallone, Maria C Piccirillo, Guglielmo Nasti, Gerardo Rosati, Chiara Carlomagno, Anna Nappi

JAMA Netw Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview.
Cristina Ferrari, Nicola Maggialetti, Tamara Masi, Anna Giulia Nappi, Giulia Santo

J Pers Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Alessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, Anna Maria Trotta, Crescenzo D'Alterio, Anna Nappi

Ther Adv Med Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by F-FDG PET/CT.
Artor Niccoli Asabella, Anna Giulia Nappi, Orsola Trani, Angela Sardaro, Giuseppe Rubini

Diagnostics (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study.
Viviana Frantellizzi, Fabio Monari, Manlio Mascia, Renato Costa, Giuseppe Rubini, Anna Giulia Nappi

Int J Radiat Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with -mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Antonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, Carmela Romano, Filomena Calabrese, Anna Nappi

Ther Adv Med Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis